Data as of Jul 30
| -0.01 / -0.01%|
The 14 analysts offering 12-month price forecasts for DaVita HealthCare Partners Inc have a median target of 75.00, with a high estimate of 86.00 and a low estimate of 56.00. The median estimate represents a +5.16% increase from the last price of 71.32.
The current consensus among 18 polled investment analysts is to Buy stock in DaVita HealthCare Partners Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.